Decoy Therapeutics Inc. (NASDAQ:DCOY)
Insiders here have filed 10 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$14.4M
- Net margin
- —
Little or no net debt.
- Total debt
- $0
- Cash
- $8.3M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $8.6M
- Current liabilities
- $4.7M
- Current ratio
- 1.83
Consumes cash and must keep raising it.
- Operating cash flow
- -$8.3M
- Free cash flow
- -$8.4M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 0.5M
- Share growth (1y)
- 275.9%
- Cash runway
- 12 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DCOY Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 8.52 M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -8.52 M | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.33 M | 1.53 M | 403.27 K | 833.30 K | 849.18 K | 1.64 M |
| R&D Expense | 1.30 M | 749.81 K | 114.43 K | 61.83 K | 116.38 K | 75.53 K |
| Operating Expenses | 2.63 M | 2.28 M | 517.70 K | 895.13 K | 965.57 K | 1.72 M |
| Operating Income | -2.63 M | -2.28 M | -9.03 M | -895.13 K | -965.57 K | -1.72 M |
| Pretax Income | -2.37 M | -2.22 M | -8.98 M | -873.47 K | -957.83 K | -1.71 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.37 M | -2.22 M | -8.98 M | -873.47 K | -957.83 K | -1.71 M |
| EPS (Basic) | -4.46 | -4.18 | -18.64 | -1.81 | -6.77 | -15.41 |
| EPS (Diluted) | -4.46 | -4.18 | -18.64 | -1.81 | -6.77 | -15.41 |
| Shares Outstanding | 531.97 K | 531.97 K | 481.59 K | 481.59 K | 141.52 K | 110.93 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.